Table 2. The Outcomes of Each Study.
| The outcome: Stroke incidence (Events/Total, n/N) | The outcome: All-cause death (Events/Total, n/N) | The outcome: Ischemic stroke (Events/Total, n/N) | The outcome: Cerebral/intracranial hemorrhage (Events/Total, n/N) | The outcome: TIA (Events/Total, n/N) | The outcome: Any bleeding without intracranial hemorrhage (Events/Total, n/N) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dual group | Mono group | Dual group | Mono group | Dual group | Mono group | Dual group | Mono group | Dual group | Mono group | Dual group | Mono group | |
| Kennedy J 2007 16 | 5/98 | 9/95 | - | - | - | - | - | - | - | - | - | - |
| Wong KSL 2010 17 | 0/46 | 1/52 | - | - | 0/46 | 2/52 | - | - | 2/46 | 1/52 | 2/46 | 0/52 |
| Wang Y 2013 18 | 212/2584 | 303/2586 | 10/2584 | 10/2586 | 204/2584 | 295/2586 | 8/2584 | 8/2586 | 39/2584 | 47/2586 | 60/2584 | 41/2586 |
| Bhatt DL 2006 20 | 150/7802 | 189/7801 | 371/7802 | 374/7801 | 132/7802 | 163/7801 | 26/7802 | 27/7801 | - | - | 320/7802 | 222/7801 |
| Benavente OR 2012 19 | 125/1517 | 138/1503 | 113/1517 | 77/1503 | 100/1517 | 124/1503 | 21/1517 | 13/1503 | 28/1517 | 39/1503 | 87/1517 | 42/1503 |
Dual: Dual therapy with clopidogrel and aspirin;Mono: monotherapy with aspirin alone.